JMP Securities Sticks to Their Hold Rating for Atlassian (TEAM)
In a report released today, Patrick Walravens from JMP Securities maintained a Hold rating on Atlassian (TEAM – Research Report). The company’s ...
JMP Securities Keeps Their Buy Rating on LPL Financial (LPLA)
JMP Securities analyst Devin Ryan reiterated a Buy rating on LPL Financial (LPLA – Research Report) today and set a price target of $435.00.
Why Pharvaris (PHVS) Is Advancing Today
Pharvaris (PHVS) is climbing 3% after investment bank JMP Securities raised its price target on the shares to $55, based on ...
JMP Securities sets $19 target for Kalvista Pharmaceuticals stock
JMP Securities initiated coverage on Kalvista Pharmaceuticals Inc (NASDAQ: KALV), assigning a Market Outperform rating and setting a price target of $19.00. Currently trading at $8.77, the stock has ...
JMP Securities starts Astria Therapeutics stock at Market Outperform
JMP Securities initiated coverage on Astria Therapeutics (NASDAQ: ATXS), assigning a Market Outperform rating and setting a ...